nach oben

Erschienen in:

16.09.2021 | COVID-19 | Original Article Zur Zeit gratis

Vertebral fractures and mortality risk in hospitalised patients during the COVID-19 pandemic emergency

verfasst von: Sofia Battisti, Nicola Napoli, Claudio Pedone, Mariangela Lombardi, Giulia Leanza, Flavia Tramontana, Malak Faraj, Vanni Agnoletti, Martina Verna, Lorenzo Viola, Emanuela Giampalma, Rocky Strollo

Erschienen in: Endocrine | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Background and objective

Bone fragility has been linked to COVID-19 severity. The objective of this study was to evaluate whether a diagnosis of vertebral fracture (VF) increased mortality risk in COVID-19 patients and whether this effect was greater than in those without COVID-19.

Methods

We assessed VFs by computed tomography (CT) in a cohort of 501 patients consecutively admitted to the emergency department (ED) for clinical suspicion of SARS-CoV-2 infection during the first wave of pandemic emergency. Of those, 239 had a confirmed diagnosis of COVID-19.

Results

VF prevalence was similar between COVID-19 and non-COVID-19 groups (22.2 vs. 19%; p = 0.458). Death rates were similar between COVID-19 and non-COVID-19 groups at both 30 (15.8 vs. 12.2%; p = 0.234) and 120 days (21.8 vs. 17.6%; p = 0.236). The mortality risk was higher in COVID-19 patients either with one or multiple fractures compared to those without VFs, at 30 and 120 days, but statistical significance was reached only in those with multiple VFs (30-day HR 3.03, 95% CI 1.36–6.75; 120-day HR 2.91, 95% CI 1.43–5.91). In the non-COVID-19 group, the 30-day mortality risk was significantly higher in patients either with one (HR 7.46, 95% CI 3.12–17.8) or multiple fractures (HR 6.2, 95% CI 2.75–13.98) compared to those without VFs. A similar effect was observed at 120 days. After adjustment for age, sex and bone density, mortality risk remained associated with VFs in the non-COVID-19 group only.

Conclusions

VFs were not independently associated with short-term mortality in patients with COVID-19, but they strongly increased mortality risk in those without COVID-19.

World Health Organization. Coronavirus (COVID-19) Dashboard. (WHO, 2020). https://www.covid19.who.int

A. Emami, F. Javanmardi, N. Pirbonyeh, A. Akbari, Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Arch. Acad. Emerg. Med. 8(1), e35 (2020)PubMedPubMedCentral

S. Battisti, C. Pedone, N. Napoli, E. Russo, V. Agnoletti, S.G. Nigra et al. Computed tomography highlights increased visceral adiposity associated with critical illness in COVID-19. Diabetes Care 43(10), e129–e130 (2020). https://doi.org/10.2337/dc20-1333CrossRefPubMed

S. Richardson, J.S. Hirsch, M. Narasimhan, J.M. Crawford, T. McGinn, K.W. Davidson et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 323(20), 2052–2059 (2020). https://doi.org/10.1001/jama.2020.6775CrossRefPubMedPubMedCentral

G. Onder, G. Rezza, S. Brusaferro, Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 323(18), 1775–1776 (2020). https://doi.org/10.1001/jama.2020.4683CrossRefPubMed

K. Aoyagi, P.D. Ross, J.W. Davis, R.D. Wasnich, T. Hayashi, T. Takemoto, Falls among community-dwelling elderly in Japan. J. Bone Miner. Res. 13(9), 1468–1474 (1998). https://doi.org/10.1359/jbmr.1998.13.9.1468CrossRefPubMed

B.L. Riggs, L.J. Melton 3rd, Involutional osteoporosis. N. Engl J. Med. 314(26), 1676–1686 (1986). https://doi.org/10.1056/NEJM198606263142605CrossRefPubMed

C. Schlaich, H.W. Minne, T. Bruckner, G. Wagner, H.J. Gebest, M. Grunze et al. Reduced pulmonary function in patients with spinal osteoporotic fractures. Osteoporos. Int. 8(3), 261–267 (1998). https://doi.org/10.1007/s001980050063CrossRefPubMed

I. Lombardi Jr., L.M. Oliveira, A.F. Mayer, J.R. Jardim, J. Natour, Evaluation of pulmonary function and quality of life in women with osteoporosis. Osteoporos. Int. 16(10), 1247–1253 (2005). https://doi.org/10.1007/s00198-005-1834-3CrossRefPubMed

10.

T. Munhoz da Rocha Lemos Costa, F.M. Costa, T. Hoffman Jonasson, C. Aguiar Moreira, C.L. Boguszewski, J.L. Cunha Borges et al. Bone mineral density and vertebral fractures and their relationship with pulmonary dysfunction in patients with chronic obstructive pulmonary disease. Osteoporos. Int. 29(11), 2537–2543 (2018). https://doi.org/10.1007/s00198-018-4643-1CrossRefPubMed

11.

R.M. Francis, T.J. Aspray, G. Hide, A.M. Sutcliffe, P. Wilkinson, Back pain in osteoporotic vertebral fractures. Osteoporos. Int. 19(7), 895–903 (2008). https://doi.org/10.1007/s00198-007-0530-xCrossRefPubMed

12.

K.E. Ensrud, D.E. Thompson, J.A. Cauley, M.C. Nevitt, D.M. Kado, M.C. Hochberg et al. Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group. J. Am. Geriatr. Soc. 48(3), 241–249 (2000). https://doi.org/10.1111/j.1532-5415.2000.tb02641.xCrossRefPubMed

13.

O. Johnell, J.A. Kanis, A. Oden, I. Sernbo, I. Redlund-Johnell, C. Petterson et al. Mortality after osteoporotic fractures. Osteoporos. Int. 15(1), 38–42 (2004). https://doi.org/10.1007/s00198-003-1490-4CrossRefPubMed

14.

L. di Filippo, A.M. Formenti, M. Doga, E. Pedone, P. Rovere-Querini, A. Giustina, Radiological thoracic vertebral fractures are highly prevalent in COVID-19 and predict disease outcomes. J. Clin. Endocrinol. Metab. 106(2), e602–e614 (2021). https://doi.org/10.1210/clinem/dgaa738CrossRefPubMed

15.

J. Kottlors, N. Große Hokamp, P. Fervers, J. Bremm, F. Fichter, T. Persigehl et al. Early extrapulmonary prognostic features in chest computed tomography in COVID-19 pneumonia: Bone mineral density is a relevant predictor for the clinical outcome—a multicenter feasibility study. Bone 144, 115790 (2021). https://doi.org/10.1016/j.bone.2020.115790CrossRefPubMed

16.

European Prospective Osteoporosis Study Group, D. Felsenberg, A.J. Silman, M. Lunt, G. Armbrecht, A.A. Ismail et al. Incidence of vertebral fracture in Europe: results from the European Prospective Osteoporosis Study (EPOS). J. Bone Miner. Res. 17(4), 716–724 (2002). https://doi.org/10.1359/jbmr.2002.17.4.716

17.

H.K. Genant, M. Jergas, L. Palermo, M. Nevitt, R.S. Valentin, D. Black et al. Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis The Study of Osteoporotic Fractures Research Group. J. Bone Miner. Res. 11(7), 984–996 (1996). https://doi.org/10.1002/jbmr.5650110716CrossRefPubMed

18.

C.F. Buckens, G. Dijkhuis, B. de Keizer, H.J. Verhaar, P.A. de Jong, Opportunistic screening for osteoporosis on routine computed tomography? An external validation study. Eur. Radiol. 25(7), 2074–2079 (2015). https://doi.org/10.1007/s00330-014-3584-0CrossRefPubMed

19.

P.J. Pickhardt, B.D. Pooler, T. Lauder, A.M. del Rio, R.J. Bruce, N. Binkley, Opportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications. Ann. Intern. Med. 158(April), 588–595 (2013). https://doi.org/10.7326/0003-4819-158-8-201304160-00003CrossRefPubMedPubMedCentral

20.

D.P. Ahern, J.M. McDonnell, M. Riffault, S. Evans, S.C. Wagner, A.R. Vaccaro, D.A. Hoey, J.S. Butler, A meta-analysis of the diagnostic accuracy of hounsfield units on computed topography relative to dual-energy X-ray absorptiometry for the diagnosis of osteoporosis in the spine surgery population. Spine J. S1529-9430(March), 00119–4 (2021). https://doi.org/10.1016/j.spinee.2021.03.008CrossRef

21.

D. Bliuc, N.D. Nguyen, V.E. Milch, T.V. Nguyen, J.A. Eisman, J.R. Center, Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301(5), 513–521 (2009). https://doi.org/10.1001/jama.2009.50CrossRefPubMed

22.

F. Zhou, T. Yu, R. Du, G. Fan, Y. Liu, Z. Liu et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 395(10229), 1054–1062 (2020). https://doi.org/10.1016/S0140-6736(20)30566-3CrossRefPubMedPubMedCentral

23.

R.H. Du, L.R. Liang, C.Q. Yang, W. Wang, T.Z. Cao, M. Li, et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur. Respir. J. 55(5), (2020). https://doi.org/10.1183/13993003.00524-2020

24.

J. Qian, L. Zhao, R.Z. Ye, X.J. Li, Y.L. Liu, Age-dependent gender differences in COVID-19 in Mainland China: comparative study. Clin. Infect. Dis. 71(9), 2488–2494 (2020). https://doi.org/10.1093/cid/ciaa683CrossRefPubMed

25.

V. Bajaj, N. Gadi, A.P. Spihlman, S.C. Wu, C.H. Choi, V.R. Moulton, Aging, immunity, and COVID-19: how age influences the host immune response to Coronavirus infections? Front. Physiol. 11, 571416 (2020). https://doi.org/10.3389/fphys.2020.571416CrossRefPubMed

26.

N. Gadi, S.C. Wu, A.P. Spihlman, V.R. Moulton, What’s sex got to do with COVID-19? Gender-based differences in the host immune response to Coronaviruses. Front. Immunol. 11, 2147 (2020). https://doi.org/10.3389/fimmu.2020.02147CrossRefPubMedPubMedCentral

27.

Center for Disease Control and Prevention. Framework for Healthcare Systems Providing Non-COVID-19 Clinical Care During the COVID-19 Pandemic. (2020). https://www.cdc.gov/coronavirus/2019-ncov/hcp/framework-non-COVID-care.html

28.

B. Metzler, P. Siostrzonek, R.K. Binder, A. Bauer, S.J. Reinstadler, Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage. Eur. Heart J. 41(19), 1852–1853 (2020). https://doi.org/10.1093/eurheartj/ehaa314CrossRefPubMed

29.

O. De Filippo, F. D’Ascenzo, F. Angelini, P.P. Bocchino, F. Conrotto, A. Saglietto et al. Reduced rate of hospital admissions for ACS during Covid-19 outbreak in Northern Italy. N. Engl J. Med. 383(1), 88–89 (2020). https://doi.org/10.1056/NEJMc2009166CrossRefPubMed

30.

A. Holt, G.H. Gislason, M. Schou, B. Zareini, T. Biering-Sorensen, M. Phelps et al. New-onset atrial fibrillation: incidence, characteristics, and related events following a national COVID-19 lockdown of 5.6 million people. Eur. Heart J. 41(32), 3072–3079 (2020). https://doi.org/10.1093/eurheartj/ehaa494CrossRefPubMed

31.

J. Mesnier, Y. Cottin, P. Coste, E. Ferrari, F. Schiele, G. Lemesle et al. Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France: a registry study. Lancet Public Health 5(10), e536–e542 (2020). https://doi.org/10.1016/S2468-2667(20)30188-2CrossRefPubMedPubMedCentral

32.

S. De Rosa, C. Spaccarotella, C. Basso, M.P. Calabro, A. Curcio, P.P. Filardi et al. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur. Heart J. 41(22), 2083–2088 (2020). https://doi.org/10.1093/eurheartj/ehaa409CrossRefPubMed

33.

S. Garcia, M.S. Albaghdadi, P.M. Meraj, C. Schmidt, R. Garberich, F.A. Jaffer et al. Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic. J. Am. Coll. Cardiol. 75(22), 2871–2872 (2020). https://doi.org/10.1016/j.jacc.2020.04.011CrossRefPubMedPubMedCentral

34.

M.D. Solomon, E.J. McNulty, J.S. Rana, T.K. Leong, C. Lee, S.H. Sung et al. The Covid-19 pandemic and the incidence of acute myocardial infarction. N. Engl J. Med. 383(7), 691–693 (2020). https://doi.org/10.1056/NEJMc2015630CrossRefPubMed

35.

A.S. Pandey, B.J. Daou, J.P. Tsai, S.F. Zaidi, H. Salahuddin, J.J. Gemmete et al. Letter: COVID-19 pandemic—the Bystander effect on stroke care in Michigan. Neurosurgery 87(3), E397–E399 (2020). https://doi.org/10.1093/neuros/nyaa252CrossRefPubMed

36.

A.S. Bhatt, A. Moscone, E.E. McElrath, A.S. Varshney, B.L. Claggett, D.L. Bhatt et al. Fewer Hospitalizations for acute cardiovascular conditions during the COVID-19 pandemic. J. Am. Coll. Cardiol. 76(3), 280–288 (2020). https://doi.org/10.1016/j.jacc.2020.05.038CrossRefPubMedPubMedCentral

37.

D.I. Bromage, A. Cannata, I.A. Rind, C. Gregorio, S. Piper, A.M. Shah et al. The impact of COVID-19 on heart failure hospitalization and management: report from a Heart Failure Unit in London during the peak of the pandemic. Eur. J. Heart Fail. 22(6), 978–984 (2020). https://doi.org/10.1002/ejhf.1925CrossRefPubMed

38.

J.D. Figueroa, P.M. Brennan, et al. Distinguishing between direct and indirect consequences of covid-19. BMJ. 369, m2377 (2020). https://doi.org/10.1136/bmj.m2377

39.

Office for National Statistics. Deaths involving COVID-19, England and Wales: deaths occurring in April 2020. (2020) https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsinvolvingcovid19englandandwales/deathsoccurringinapril2020

40.

European Stroke Organisation. Likely increase in the risk of death or disability from stroke during the COVID-19 pandemic. (2020). https://eso-stroke.org/eso/likely-increase-in-the-risk-of-death-or-disability-from-stroke-during-the-covid-19-pandemic/

41.

L.M. Rossen, A.M. Branum, F.B. Ahmad, P. Sutton, R.N. Anderson, Excess deaths associated with COVID-19, by age and race and ethnicity—United States, January 26-October 3, 2020. Morb. Mortal. Wkly Rep. 69(42), 1522–1527 (2020). https://doi.org/10.15585/mmwr.mm6942e2CrossRef

42.

A. Bilinski, E.J. Emanuel, COVID-19 and excess all-cause mortality in the US and 18 comparison countries. JAMA 324(20), 2100–2102 (2020). https://doi.org/10.1001/jama.2020.20717CrossRefPubMedPubMedCentral

43.

N. Napoli, A.L. Elderkin, D.P. Kiel, S. Khosla, Managing fragility fractures during the COVID-19 pandemic. Nat. Rev. Endocrinol. 16(9), 467–468 (2020). https://doi.org/10.1038/s41574-020-0379-zCrossRefPubMedPubMedCentral

44.

E.W. Yu, E. Tsourdi, B.L. Clarke, D.C. Bauer, M.T. Drake, Osteoporosis management in the era of COVID-19. J. Bone Miner. Res. 35(6), 1009–1013 (2020). https://doi.org/10.1002/jbmr.4049CrossRefPubMed

45.

F. Tramontana, N. Napoli, G. El-Hajj Fuleihan, R. Strollo, The D-side of COVID-19: musculoskeletal benefits of vitamin D and beyond. Endocrine 69(2), 237–240 (2020). https://doi.org/10.1007/s12020-020-02407-0CrossRefPubMedPubMedCentral

Titel: Vertebral fractures and mortality risk in hospitalised patients during the COVID-19 pandemic emergency
verfasst von: Sofia Battisti
Nicola Napoli
Claudio Pedone
Mariangela Lombardi
Giulia Leanza
Flavia Tramontana
Malak Faraj
Vanni Agnoletti
Martina Verna
Lorenzo Viola
Emanuela Giampalma
Rocky Strollo
Publikationsdatum: 16.09.2021
Verlag: Springer US
Schlagwort: COVID-19
Erschienen in: Endocrine / Ausgabe 3/2021
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-021-02872-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Vertebral fractures and mortality risk in hospitalised patients during the COVID-19 pandemic emergency

Abstract

Background and objective

Methods

Results

Conclusions

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Background and objective

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2021

Mild progressive osseous heteroplasia overlap syndrome with PTH and TSH resistance appearing during adolescence and not early childhood

ARISE—a prospective, non-interventional, single-arm study assessing clinical parameters associated with the use of insulin degludec/insulin aspart in patients with type 2 diabetes in real-world settings: rationale and design

Polycystic ovary syndrome is an independent risk factor for hypertensive disorders of pregnancy: A systematic review, meta-analysis, and meta-regression

Surgical outcomes in the pheochromocytoma surgery. Results from the PHEO-RISK STUDY

Response to Letter to “Levothyroxine absorption test results in patients with TSH elevation resistant to treatment”

Triglyceride glucose-waist to height ratio: a novel and effective marker for identifying hepatic steatosis in individuals with type 2 diabetes mellitus

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin